These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23418021)

  • 1. Health care expenditures from living longer--how much do they matter.
    Gandjour A
    Int J Health Plann Manage; 2014; 29(1):43-51. PubMed ID: 23418021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging diseases--do they prevent preventive health care from saving costs?
    Gandjour A
    Health Econ; 2009 Mar; 18(3):355-62. PubMed ID: 18833543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Savings needed to fund health insurance and health care expenses in retirement: findings from a simulation model.
    Fronstin P; Salisbury D; VanDerhei J
    EBRI Issue Brief; 2008 May; (317):1-2, 4-27. PubMed ID: 18630312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health expenditure estimation and functional form: applications of the generalized gamma and extended estimating equations models.
    Hill SC; Miller GE
    Health Econ; 2010 May; 19(5):608-27. PubMed ID: 19434646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What length of hospice use maximizes reduction in medical expenditures near death in the US Medicare program?
    Taylor DH; Ostermann J; Van Houtven CH; Tulsky JA; Steinhauser K
    Soc Sci Med; 2007 Oct; 65(7):1466-78. PubMed ID: 17600605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing longevity and Medicare expenditures.
    Miller T
    Demography; 2001 May; 38(2):215-26. PubMed ID: 11392909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
    Kwan SW; Mortell KE; Hippe DS; Brunner MC
    J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the future healthcare costs of an aging population in the UK: expansion of morbidity and the need for preventative care.
    Caley M; Sidhu K
    J Public Health (Oxf); 2011 Mar; 33(1):117-22. PubMed ID: 20534629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of major adult visual disorders in the United States.
    Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
    Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Medicare savings through prevention and risk reduction.
    Rula EY; Pope JE; Hoffman JC
    Popul Health Manag; 2011 Feb; 14 Suppl 1():S35-44. PubMed ID: 21323619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health care expenditures and the aging population].
    Felder S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):614-21. PubMed ID: 22526849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State- and payer-specific estimates of annual medical expenditures attributable to obesity.
    Trogdon JG; Finkelstein EA; Feagan CW; Cohen JW
    Obesity (Silver Spring); 2012 Jan; 20(1):214-20. PubMed ID: 21681222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A parsimonious model to validate cost-effectiveness analyses on preventive health care.
    Gandjour A
    BMC Health Serv Res; 2021 Nov; 21(1):1213. PubMed ID: 34753466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospice Use, Hospitalization, and Medicare Spending at the End of Life.
    Zuckerman RB; Stearns SC; Sheingold SH
    J Gerontol B Psychol Sci Soc Sci; 2016 May; 71(3):569-80. PubMed ID: 26655645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs.
    Daviglus ML; Liu K; Greenland P; Dyer AR; Garside DB; Manheim L; Lowe LP; Rodin M; Lubitz J; Stamler J
    N Engl J Med; 1998 Oct; 339(16):1122-9. PubMed ID: 9770560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Specific Combinations of Multimorbidity that Contribute to Health Care Resource Utilization: An Analytic Approach.
    Schiltz NK; Warner DF; Sun J; Bakaki PM; Dor A; Given CW; Stange KC; Koroukian SM
    Med Care; 2017 Mar; 55(3):276-284. PubMed ID: 27753745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical objections against including life-extension costs in cost-effectiveness analysis: a consistent approach.
    Gandjour A; Müller D
    Appl Health Econ Health Policy; 2014 Oct; 12(5):471-6. PubMed ID: 25027546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of proximity to death in modelling community medication expenditures for older people: evidence from New Zealand.
    Moore PV; Bennett K; Normand C
    Appl Health Econ Health Policy; 2014 Dec; 12(6):623-33. PubMed ID: 25141830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.